CA2207334C - Preparations granulaires a liberation prolongee et procede pour leur production - Google Patents
Preparations granulaires a liberation prolongee et procede pour leur production Download PDFInfo
- Publication number
- CA2207334C CA2207334C CA002207334A CA2207334A CA2207334C CA 2207334 C CA2207334 C CA 2207334C CA 002207334 A CA002207334 A CA 002207334A CA 2207334 A CA2207334 A CA 2207334A CA 2207334 C CA2207334 C CA 2207334C
- Authority
- CA
- Canada
- Prior art keywords
- sustained
- granules
- polymer
- plasticizer
- granular preparations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
La présente invention concerne une préparation granulaire à libération prolongée qui est excellente pour ce qui concerne la diffusion lente et inoffensive pour l'organisme humain. Elle peut être produite aisément, d'une manière simple, par granulation par voie humide d'une suspension aqueuse contenant un principe actif efficace sur le plan médical, un polymère particulaire ayant un diamètre moyen de particules de 50 <m ou moins, et un plastifiant, et par traitement des granulés obtenus à la plus basse des températures suivantes: la plus basse température de formation d'un film pour un mélange du polymère et du plastifiant, et sa température de transition vitreuse.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP314414/1994 | 1994-12-19 | ||
JP31441494 | 1994-12-19 | ||
PCT/JP1995/002594 WO1996019200A1 (fr) | 1994-12-19 | 1995-12-18 | Preparation granulaire a liberation prolongee et procede de production |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2207334A1 CA2207334A1 (fr) | 1996-06-27 |
CA2207334C true CA2207334C (fr) | 2006-08-22 |
Family
ID=36939171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002207334A Expired - Fee Related CA2207334C (fr) | 1994-12-19 | 1995-12-18 | Preparations granulaires a liberation prolongee et procede pour leur production |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2207334C (fr) |
-
1995
- 1995-12-18 CA CA002207334A patent/CA2207334C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2207334A1 (fr) | 1996-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6030644A (en) | Sustained-release granular preparations and production process thereof | |
JP3019235B2 (ja) | スフェロイド製剤 | |
JP3265680B2 (ja) | 経口製剤用組成物 | |
JP3470198B2 (ja) | 経口投与用組成物 | |
US5389380A (en) | Sustained release pharmaceutical preparation and process for preparing the same | |
EP0834314B1 (fr) | Granules contenant du pranlukast, procede de production des granules et procede de reduction de la cohesion du pranlukast | |
JP2000169364A (ja) | 経口製剤用粒子 | |
JP2973751B2 (ja) | 矯味経口組成物の製造方法 | |
JP2958863B2 (ja) | プランルカストを含有する造粒物、その製造方法およびプランルカストの付着凝集性改善方法 | |
CN1355692A (zh) | 遮味的组合物 | |
KR100913281B1 (ko) | 서방 제제 및 그의 제조 방법 | |
CA2207334C (fr) | Preparations granulaires a liberation prolongee et procede pour leur production | |
JP2004339162A (ja) | 難溶性薬物を含む医薬用固形製剤とその製造方法 | |
WO2000018372A1 (fr) | Granules pour preparations orales | |
JP4711478B2 (ja) | 味がマスクされた薬物 | |
JP3372242B2 (ja) | 徐放性微粒子製剤及びその製造方法 | |
JP2012087073A (ja) | コーティング粒子の製造方法、及び該製造方法で製造されたコーティング粒子 | |
JP2915653B2 (ja) | マスクされた粒状物 | |
KR20130095297A (ko) | Hcv 감염의 치료를 위한 약학 조성물 | |
GB2258613A (en) | Pharmaceutical diltiazem spheroid formulation | |
JPWO2003032998A1 (ja) | 徐放性微粒子及びその製造方法 | |
MXPA99011317A (en) | Solid pharmaceutical dosage forms in form of a particulate dispersion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |